X-148024880-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152578.3(FMR1NB):āc.648T>Gā(p.Asp216Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000252 in 1,207,944 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 109 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152578.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMR1NB | NM_152578.3 | c.648T>G | p.Asp216Glu | missense_variant | 5/6 | ENST00000370467.8 | NP_689791.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMR1NB | ENST00000370467.8 | c.648T>G | p.Asp216Glu | missense_variant | 5/6 | 1 | NM_152578.3 | ENSP00000359498.3 | ||
FMR1NB | ENST00000489034.2 | n.135T>G | non_coding_transcript_exon_variant | 3/5 | 3 | ENSP00000435769.2 |
Frequencies
GnomAD3 genomes AF: 0.000179 AC: 20AN: 111729Hom.: 0 Cov.: 22 AF XY: 0.000147 AC XY: 5AN XY: 33961
GnomAD3 exomes AF: 0.000105 AC: 19AN: 181633Hom.: 0 AF XY: 0.000136 AC XY: 9AN XY: 66275
GnomAD4 exome AF: 0.000260 AC: 285AN: 1096215Hom.: 0 Cov.: 30 AF XY: 0.000287 AC XY: 104AN XY: 361913
GnomAD4 genome AF: 0.000179 AC: 20AN: 111729Hom.: 0 Cov.: 22 AF XY: 0.000147 AC XY: 5AN XY: 33961
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 11, 2024 | The c.648T>G (p.D216E) alteration is located in exon 5 (coding exon 5) of the FMR1NB gene. This alteration results from a T to G substitution at nucleotide position 648, causing the aspartic acid (D) at amino acid position 216 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at